Plasma lactate and leukocyte mitochondrial DNA copy number as biomarkers of insulin sensitivity in non-diabetic women
- 25 Downloads
High plasma lactate levels have been associated with reduced mitochondrial respiratory capacity and increased type 2 diabetes risk, while mitochondrial DNA (mtDNA) copy number has been proposed as a biomarker of mitochondrial function linked to glucose homeostasis. The aim of this study was to evaluate the association between circulating lactate levels and leukocyte mtDNA copy numbers with insulin secretion/sensitivity indexes in 65 Chilean non-diabetic women. mtDNA copy numbers were measured in leukocytes using qPCR and digital-droplet PCR. A 75-g Oral Glucose Tolerance Test (OGTT) was performed to calculate systemic and tissue-specific insulin sensitivity indexes, as well as insulin secretion surrogates based on plasma c-peptide. An intravenous glucose tolerance test (IVGTT; 0.3 g/kg) was also carried out. Disposition indexes were calculated as the product of insulin secretion × sensitivity. Plasma levels of leptin, adiponectin, TNF-α, MCP-1, and non-esterified fatty acids were also determined. Fasting plasma lactate shows a significant association with a wide range of insulin sensitivity/resistance indexes based on fasting plasma samples (HOMA-S, adipose IR index, Revised-QUICKI, leptin-adiponectin ratio, TyG index, McAuley index and TG-to-HDL-C ratio), as well as OGTT-based measures such as the Matsuda index, the hepatic insulin resistance index, and the disposition index. Fasting plasma lactate was also positively associated with the circulating adipokines TNF-α and MCP-1. We also detected a direct association between fasting plasma lactate with leukocyte mtDNA copy numbers. The above results support the use of fasting plasma lactate, and possibly leukocyte mtDNA copy numbers, as biomarkers of reduced oxidative mitochondrial capacity, decreased hepatic insulin sensitivity, and future diabetes risk.
KeywordsLactate Mitochondrial DNA Insulin sensitivity Biomarker Diabetes
This study was supported by the Chilean Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT; projects 1150416 and 1170117), the Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERobn), Institute of Health Carlos III, Madrid, Spain (CB12/03/30002) and Ministerio de Economía y Competitividad (AGL2013-4554-R).
Compliance with ethical standards
All participants signed written informed consent and the research protocol was approved by the Ethics Committee of the School of Medicine of the Pontificia Universidad Católica de Chile.
Conflict of interest
The authors declare that they have no conflict of interest.
- 26.Knez J, Winckelmans E, Plusquin M, Thijs L, Cauwenberghs N, Gu Y, Staessen JA, Nawrot TS, Kuznetsova T (2016) Correlates of peripheral blood mitochondrial DNA content in a general population. Am J Epidemiol 183:138–146Google Scholar
- 44.Santos JL, Yévenes I, Cataldo LR, Morales M, Galgani J, Arancibia C, Vega J, Olmos P, Flores M, Valderas JP, Pollak F (2016) Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status. J Physiol Biochem 72:121–131CrossRefGoogle Scholar
- 58.Zhou M, Zhu L, Cui X, Feng L, Zhao X, He S, Ping F, Li W, Li Y (2016) Reduced peripheral blood mtDNA content is associated with impaired glucose-stimulated islet β cell function in a Chinese population with different degrees of glucose tolerance. Diabetes Metab Res Rev 32:768–774CrossRefGoogle Scholar